Skip to main content
Home / Resources / Conferences / Antibody Engineering & Therapeutics

Antibody Engineering & Therapeutics

Antibody Engineering & Therapeutics

We are excited to be presenting at this conference

Bridging the in vitro to in vivo Gap for T-cell Engagers Using QSP Modeling

David Flowers, PhD, Director at Certara

The unique cell-to-cell crosslinking action of T-cell engagers (TCEs) poses challenges for in vitro to in vivo translation. Recent advances in QSP models of TCEs capture key biophysical details of crosslinking, enabling rational techniques for first-in-human dose selection and efficacious dose prediction from in vitro potency assays and preclinical animal studies. This talk will review these developments and explain how QSP models can support and accelerate TCE development.